Your browser doesn't support javascript.
loading
Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
Kim, Changsoo; Rhie, Seonkyeong; Suh, Mina; Kang, Dae Ryong; Choi, Yoon Jung; Bae, Geun-Ryang; Choi, Young-Chul; Jun, Byung Yool; Lee, Joon Soo.
Affiliation
  • Kim C; Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Rhie S; Department of Pediatrics, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
  • Suh M; National Cancer Center, Goyang, Republic of Korea.
  • Kang DR; Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Choi YJ; Health Insurance Review and Assessment Service, Seoul, Republic of Korea.
  • Bae GR; Korea Centers for Disease Control and Prevention, Osong, Republic of Korea.
  • Choi YC; Department of Neurology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea.
  • Jun BY; Department of International Health Science, Graduate School of Public Health, Yonsei University, Seoul, Korea.
  • Lee JS; Department of Pediatrics, Severance Children's Hospital, Epilepsy Research Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: JOONSL96@yuhs.ac.
Vaccine ; 33(15): 1815-23, 2015 Apr 08.
Article in En | MEDLINE | ID: mdl-25728315
ABSTRACT

BACKGROUND:

Many studies have investigated the association between Guillain-Barré syndrome (GBS) and vaccinations during the influenza A H1N1 pandemic of 2009 (pH1N1). Based on a nationally representative sample, we estimated the incidence of GBS during the pandemic period in Korea. MATERIALS AND

METHODS:

All medical records of GBS cases were reviewed in 28 randomly selected hospitals during 2008-2010, and the number of GBS cases at the national level was extrapolated using emergency care utilization data. The GBS rate per 100,000 person-years was estimated in the reference and pandemic periods.

RESULTS:

The incidence of GBS was 0.63 (95% CI 0.37-0.89) per 100,000 person-years in the reference period and 0.87 (0.49-1.26) in the pandemic period. During the vaccination season, the pandemic period GBS incidence rate was not significantly higher than the reference period incidence rate (rate ratio 1.52; 0.99-2.32), but difference was observed among persons aged 20-34 years. Rate of GBS increased after pH1N1 vaccination compared to the reference period (1.46, 1.26-1.68).

DISCUSSION:

The incidence of GBS increased slightly but not significantly during the pandemic period, although pH1N1 vaccination increased the GBS rate. Therefore, mass influenza vaccination programs should not be precluded on the basis of GBS.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / Mass Vaccination / Guillain-Barre Syndrome / Influenza, Human / Influenza A Virus, H1N1 Subtype Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2015 Type: Article

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / Mass Vaccination / Guillain-Barre Syndrome / Influenza, Human / Influenza A Virus, H1N1 Subtype Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2015 Type: Article